A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2002
10/02/2002	CN1372559A Naphthyridine derivatives processes for their preparation their use and pharmaceutical compositions comprising them
10/02/2002	CN1372556A Heterocyclic compound inhibiting angiogenesis
10/02/2002	CN1372555A Compositions and therapeutic mehtods involving isoflavones and analogues thereof
10/02/2002	CN1372544A 新颖的维生素d类似物 Novel analogues of vitamin d
10/02/2002	CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/02/2002	CN1372538A Method for producing a non-fatty softener based on wax-esters
10/02/2002	CN1372474A Methods for preventing or attenuating patthoangiogenic conditions
10/02/2002	CN1372467A Improved topical medicaments and methods for photodynamic treatment of disease
10/02/2002	CN1372453A 化学去皮剂 Chemical peeling agents
10/02/2002	CN1372450A Enhanced wound converage to enhance wound healing
10/02/2002	CN1371736A External medicine for treating burn and scald, soft tissue injury and skin disease
10/02/2002	CN1371719A Smellting treated Chinese medicine
10/02/2002	CN1371707A Traditional Chinese medicine for treating psoriasis
10/02/2002	CN1371705A Pox removing liquid
10/02/2002	CN1371693A Medicine for treating burn and scald
10/02/2002	CN1371682A Compound zinc undecylenate ointment for treating beriberi
10/02/2002	CN1371676A Sheep embryo extract face beautifying skin protection preparation
10/02/2002	CN1371675A Skin protection spot-removing cream and preparation method thereof
10/02/2002	CN1091610C Skin regrowing powder and its preparing process
10/02/2002	CN1091605C Markless burn and scald ointment
10/02/2002	CN1091592C Biological cream for treating burn and its prepn. method
10/01/2002	US6458951 For treatment of male erectile dysfunction, female sexual dysfunction
10/01/2002	US6458846 Ion channel modulating agents
10/01/2002	US6458829 Substituted γ-phenyl-Δ-lactones and analogs thereof and uses related thereto
10/01/2002	US6458827 Adjustent of conformation equilibrium; active materials
10/01/2002	US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/01/2002	US6458819 Thiazolium compounds and treatments of disorders associated with protein aging
10/01/2002	US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002	US6458805 Antagonists; especially sodium salts
10/01/2002	US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002	US6458764 GRF analogs with increased biological potency
10/01/2002	US6458564 Amino acid sequence of the protease; for treating imbalance of desquamation
10/01/2002	US6458391 Treating lesions in livestock
10/01/2002	US6458386 Medicaments based on polymers composed of methacrylamide-modified gelatin
10/01/2002	US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
10/01/2002	US6458351 Yeast extracts
10/01/2002	CA2245857C 1,4-dihydropyridine compounds as bradykinin antagonists
09/2002
09/26/2002	WO2002075304A1 Method of examining allergic disease
09/26/2002	WO2002074981A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
09/26/2002	WO2002074980A2 Muteins of hypoxia inducible factor alpha and methods of use thereof
09/26/2002	WO2002074945A1 Method for cleaving human growth hormone gh
09/26/2002	WO2002074913A2 Nucleic acid-associated proteins
09/26/2002	WO2002074806A2 New interferon beta-like molecules
09/26/2002	WO2002074771A1 Tricyclic heterocyclic compound, process for producing the same, and use
09/26/2002	WO2002074770A1 Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
09/26/2002	WO2002074767A1 Metalloproteinase inhibitors
09/26/2002	WO2002074756A2 Urokinase inhibitors
09/26/2002	WO2002074752A1 Metalloproteinase inhibitors
09/26/2002	WO2002074751A1 Metalloproteinase inhibitors
09/26/2002	WO2002074750A1 Metalloproteinase inhibitors
09/26/2002	WO2002074749A1 Metalloproteinase inhibitors
09/26/2002	WO2002074748A1 Metalloproteinase inhibitors
09/26/2002	WO2002074743A1 Aryl-substituted alicyclic compound and medical composition comprising the same
09/26/2002	WO2002074742A2 Cdk-inhibitory indirubin derivatives having an increased solubility
09/26/2002	WO2002074733A2 Tryptase-inhibitors
09/26/2002	WO2002074730A1 INHIBITORS OF INTEGRIN αvβ¿6?
09/26/2002	WO2002074346A2 Targeting chemical compounds to cells
09/26/2002	WO2002074341A1 Antipruritics
09/26/2002	WO2002074337A1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
09/26/2002	WO2002074323A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
09/26/2002	WO2002074318A1 Il-12 expression controlling agents
09/26/2002	WO2002074312A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors
09/26/2002	WO2002074301A1 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
09/26/2002	WO2002074292A2 Hormone replacement therapy
09/26/2002	WO2002074290A2 Dermatological preparations containing a nsaid
09/26/2002	WO2002074278A1 Topical composition containing an association of avocado furane lipids and isoflavones
09/26/2002	WO2002074277A1 Glabridin-based dermatological composition
09/26/2002	WO2002074239A2 Compositions and methods for the treatment and clinical remission of psoriasis
09/26/2002	WO2002074237A2 Compositions and methods for the therapy and diagnosis of kidney cancer
09/26/2002	WO2002074236A2 Skin whiteners containing hydroxytetronic acid
09/26/2002	WO2002074231A2 Cosmetic and dermopharmaceutical compositions comprising standardised extracts of hierochloe odorata
09/26/2002	WO2002062780A3 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
09/26/2002	WO2002060455A8 Methods and compositions utilizing 2'-5' oligoadenylates in the treatment of disorders of cell proliferation
09/26/2002	WO2002060382A3 Novel compounds and uses thereof
09/26/2002	WO2002055517A3 4-(hetero)aryl substituted indolinones
09/26/2002	WO2002046214A3 Immunomodulatory protein derived from the yaba monkey tumor virus
09/26/2002	WO2002045752A3 Dermal anti-inflammatory composition
09/26/2002	WO2002032872A8 Nitrogenous aromatic ring compounds
09/26/2002	WO2002032461A3 Protein c or activated protein c-like molecules
09/26/2002	WO2002032397A8 Electroprocessing in drug delivery and cell encapsulation
09/26/2002	WO2002028810A3 Retinoids for the treatment of emphysema
09/26/2002	WO2002000710A3 B7-like molecules and uses thereof
09/26/2002	WO2001098332A3 Secreted redox proteins
09/26/2002	WO2001087343A3 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
09/26/2002	WO2001083775A3 Proteases
09/26/2002	WO2001076568A3 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
09/26/2002	WO2001052847A8 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
09/26/2002	WO2001051051B1 AGENTS, SUCH AS NICOTINAMIDE OR cADPR FOR THE TREATMENT OF SKIN DISORDERS
09/26/2002	WO2001032156A3 Methods for treating fibroproliferative diseases
09/26/2002	WO2001019977A9 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
09/26/2002	WO2001019823A9 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
09/26/2002	WO2000074634A9 Methods and compositions for modulating cell proliferation and cell death
09/26/2002	WO2000027868A9 Connective tissue growth factor (ctgf) and methods of use
09/26/2002	US20020138860 Novel uses of mammalian CCR6 receptors and related reagents
09/26/2002	US20020138857 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
09/26/2002	US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example
09/26/2002	US20020137921 Oligonucleotides having chiral phosphorus linkages
09/26/2002	US20020137903 Sodium dependent glucose transporters found in the intestine and kidney (SGLT2); treating diabetes
09/26/2002	US20020137801 Administering gossypol; kits to treat patients
09/26/2002	US20020137790 Method for the production and use of a cream containing vitamin-A

1 ... 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 ... 1065